Skip to content
10-Q

Quarterly Report

CEREBAIN BIOTECH CORP.

0001477932-18-000653

← back to feed
Filed
Feb 6, 2018 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2018 · Feb 6, 2018 8.84M sh
Stockholders Equity Q2 2018 · Dec 31, 2017 −$4.75M
Stockholders Equity Q2 2018 · Jun 30, 2017 −$4.25M
Current Liabilities Q2 2018 · Dec 31, 2017 $2.23M
Current Liabilities Q2 2018 · Jun 30, 2017 $1.75M
Total Liabilities Q2 2018 · Dec 31, 2017 $4.82M
Total Liabilities Q2 2018 · Jun 30, 2017 $4.49M
Current Assets Q2 2018 · Dec 31, 2017 $68.57K
Current Assets Q2 2018 · Jun 30, 2017 $236.86K
Total Assets Q2 2018 · Dec 31, 2017 $68.57K
Total Assets Q2 2018 · Jun 30, 2017 $236.86K
Operating Cash Flow Q2 2018 · Dec 31, 2016 −$385K
Cash And Equivalents Q2 2018 · Dec 31, 2016 $1.24K
Cash And Equivalents Q2 2018 · Jun 30, 2016 $20.25K
Sga Expense Q2 2018 · Dec 31, 2016 $438.61K
Sga Expense Q2 2018 · Dec 31, 2016 $828.71K
Rd Expense Q2 2018 · Dec 31, 2016 $61.57K
Rd Expense Q2 2018 · Dec 31, 2016 $131.47K
Net Income Q2 2018 · Dec 31, 2016 −$10.69M
Net Income Q2 2018 · Dec 31, 2016 −$14.88M